triazoles has been researched along with meglumine antimoniate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J | 1 |
| Andreazza Costa, MC; Borsodi, MPG; Cabral Abreu Grijó, B; Castro Ferreira, MM; Costa, AV; Lima, WP; Rodrigues Gazolla, PA; Rossi Bergmann, B; Teixeira, RR | 1 |
2 other study(ies) available for triazoles and meglumine antimoniate
| Article | Year |
|---|---|
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles | 2017 |
Eugenol derivatives with 1,2,3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Eugenol; Female; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Mice; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Triazoles | 2022 |